Authors: Rajesh Gupta, Jim Y. Kim, Marcos A. Espinal, Jean-Michel Caudron, Bernard Pecoul, Paul E. Farmer and Mario C. Raviglione
Science Express article by Stop TB and MSF authors, presenting the Working Group for the DOTS-plus approach to achieve drug cost reductions and foster rational use and access to drugs. Includes estimated country savings on TB control if Green Light Committee (GLC) prices were available; and market status (price and supply) of second-line TB drugs.
Read the full report